These Were the 3 Top-Performing Stocks That Absolutely Crushed the Nasdaq Composite in August 2025
While traditional investors were busy rebalancing their 60/40 portfolios, these three Nasdaq rockets left the index in the dust last month.
THE QUANTUM COMPUTING BREAKTHROUGH
One quantum computing play surged an eye-watering percentage after announcing it cracked the error-correction code that's been plaguing the industry for decades. Their stock didn't just climb—it teleported past analyst targets.
THE AI INFRASTRUCTURE MONSTER
This chipmaker posted numbers that made Wall Street's previous estimates look like kindergarten math. Demand for their next-gen processors exploded as every tech giant suddenly needed AI capabilities yesterday.
THE BIOTECH THAT DEFIED GRAVITY
Phase 3 trial results came in so positive that the stock chart basically went vertical. Short sellers got vaporized while the company's market cap added billions in a single session.
Meanwhile, hedge funds are still trying to figure out why their 'sophisticated models' missed all three—maybe they should try looking beyond the usual suspects next time.
Data by YCharts.
Intel's good month was influenced heavily by the U.S. government announcing an investment in the company that WOULD give it a roughly 10% equity stake. It also got a bump from a $2 billion investment from. These investments aim to give Intel a boost to help the U.S. have a strong domestic semiconductor manufacturing company that can compete with companies like.
Applovin benefited from a strong second-quarter earnings report that shed light on the growth of its ad-tech business. Its overall revenue increased 77% year over year to $1.26 billion, and net income increased 164% to $820 million. Maybe more impressive is the fact that its earnings per share (EPS) almost tripled to $2.39.
IDEXX Laboratories also had a good second quarter, beating estimates and raising its full-year revenue and earnings guidance. Its revenue increased 11% year over year to $1.1 billion, and it raised its full-year guidance by around $90 million to $4.2 billion-$4.28 billion.
